How Pain Actually Works

July 2, 2026 12 min read The Human Machine

painnociceptionneurosciencegate-control-theorychronic-paincentral-sensitizationthe-human-machine

Contents

Pain is not a direct readout of tissue damage. It feels like one — stub a toe, feel pain proportional to the stub — but the actual pipeline between a damaged cell and the conscious experience of hurting has several distinct processing checkpoints, and every one of them can independently amplify, dampen, redirect, or in some cases manufacture a signal with only a loose relationship to what’s actually happening in the tissue. Nociception, the raw detection of a potentially damaging stimulus, is only the first stage. What you consciously experience as pain is the output of that signal after it’s been filtered through a spinal gate, potentially rerouted by an anatomical coincidence, modulated by descending signals from the brain itself, and — in a meaningful fraction of chronic pain cases — sustained by a nervous system that has changed its own wiring in ways that outlive the injury that triggered them entirely. This is a genuinely engineered-feeling signal-processing pipeline, and understanding each stage explains a set of otherwise strange facts: why rubbing a bumped elbow helps, why a heart attack can feel like a sore left arm, and why “it’s all in your head” is both an insult and, in a narrow technical sense, sometimes almost accurate — just not in the dismissive way it’s usually meant.

Nociception Is the Input Signal, Not the Output

Nociceptors are specialized free nerve endings, distributed throughout skin, muscle, joints, and viscera, tuned to respond to mechanical, thermal, or chemical stimuli intense enough to signal actual or potential tissue damage. Their job is purely detection — converting a physical or chemical event into an electrical signal — and that detection event is called nociception. Pain is a separate thing: the conscious, subjective perception that eventually results, assuming the signal makes it through every downstream stage intact. The two can dissociate in both directions. General anesthesia can block conscious pain perception while nociceptive signals still fire and trigger reflex withdrawal and autonomic responses. Conversely, as covered further below, pain can persist and even intensify with no active nociceptor signaling at all, because later stages of the pathway can sustain a pain state on their own.

The First Amplifier: Peripheral Sensitization

Before a signal even leaves the injury site, it can already be amplified. Damaged tissue releases a cocktail of inflammatory mediators — bradykinin, prostaglandins (particularly PGE2), histamine, and substance P released from the nociceptors themselves — that don’t just activate nearby nociceptors but sensitize them, lowering their firing threshold and upregulating the ion channels responsible for their response to heat, pressure, or chemical stimuli. Bradykinin and prostaglandin signaling, largely through protein kinase C-dependent pathways acting on channels like TRPV1, is well characterized as a direct driver of this effect. The clinical result is primary hyperalgesia: the area immediately around an injury becomes measurably more sensitive to a given stimulus than it was before, and more sensitive than uninjured tissue nearby — not because more nerve endings exist there, but because the ones already present have had their response curve shifted. This is why a mild pressure that would be unnoticeable on unbroken skin is sharply painful directly around a bruise or burn; the tissue itself has locally recalibrated the sensor.

Two Fiber Types, Two Timelines

Nociceptive signals travel to the spinal cord along two structurally different fiber types, and the difference explains a sensation almost everyone has felt without naming it: the distinct “double pain” of a sharp initial jab followed by a duller, delayed ache from the same injury.

A-delta fibers are thin but myelinated, which makes them fast conductors. They carry the sharp, well-localized, pricking component of pain, and they terminate in the more superficial layers of the spinal cord’s dorsal horn (laminae I and V). C fibers are unmyelinated and far slower, carrying the dull, burning, poorly localized ache, terminating in a different layer (lamina II, the substantia gelatinosa — a name that matters again in the next section). Because A-delta signals arrive first, an acute injury produces a genuinely two-stage sensory event, not a single pain signal — the fast, sharp warning followed by the slower, longer-lasting ache.

   Single injury, two arrival times at the spinal cord

   Stimulus  ---> A-delta fiber (myelinated, fast) ---> sharp, localized
       |          arrives first, ~5-30 m/s conduction    "first pain"
       |
       ---------> C fiber (unmyelinated, slow) --------> dull, burning
                  arrives later, ~0.5-2 m/s conduction   "second pain"

   Both converge on the dorsal horn but at different laminae:
   A-delta -> laminae I, V          C fiber -> lamina II (substantia gelatinosa)

The Relay: Dorsal Horn to Cortex

Once nociceptive fibers synapse in the dorsal horn, second-order neurons take over. Their axons cross the midline and ascend the spinal cord’s anterolateral quadrant as the spinothalamic tract, terminating in the ventral posterior lateral (VPL) nucleus of the thalamus. From there, third-order thalamic neurons project to the primary somatosensory cortex in the postcentral gyrus, where the signal finally becomes available to conscious awareness, alongside parallel projections to other brain regions responsible for the emotional and autonomic dimensions of the pain experience.

Stage	Structure	Role
1. Detection	Nociceptor free nerve endings	Convert mechanical/thermal/chemical stimulus to electrical signal
2. Peripheral transmission	A-delta / C fibers	Carry signal to spinal cord at different speeds
3. First relay	Dorsal horn (laminae I, II, V)	First synapse; site of the gate-control mechanism below
4. Ascending tract	Spinothalamic tract (crosses midline)	Carries signal to thalamus
5. Thalamic relay	Ventral posterior lateral nucleus	Relays to cortex
6. Cortical processing	Primary somatosensory cortex (postcentral gyrus)	Conscious localization and perception of pain

Every one of these stages is a point where the signal can be modulated rather than simply passed through unchanged — and the dorsal horn, stage 3, is where the most clinically useful modulation happens.

The Gate: Why Rubbing an Injury Actually Helps

In 1965, Ronald Melzack and Patrick Wall proposed the gate control theory of pain, locating a modulating “gate” in the substantia gelatinosa of the dorsal horn — the same layer where slow C fibers terminate. The theory’s core claim, since substantially supported by later research, is that nociceptive input from thin A-delta and C fibers competes at this relay point with non-nociceptive input from large-diameter A-beta fibers, which carry ordinary touch and pressure sensation. Strong A-beta activation closes the gate through inhibitory interneurons, reducing how much nociceptive signal gets passed up the spinothalamic tract; weak A-beta activation leaves the gate more open, letting more nociceptive signal through.

This is the actual mechanism behind an instinct everyone already has: rubbing a bumped elbow or a stubbed toe recruits large-diameter touch fibers, which competitively suppress the pain signal at the very first relay station before it ever reaches the thalamus. It’s also the working principle behind transcutaneous electrical nerve stimulation (TENS), which deliberately drives large-fiber input via surface electrodes to close the same gate therapeutically. The theory also identified a second control point beyond the spinal gate itself — descending input from the brain, covered next — which is why Melzack and Wall’s original 1965 paper is still cited as the conceptual bridge between purely peripheral and cognitively/emotionally modulated pain.

Why Pain Fools You: Referred Pain

Referred pain — feeling pain in a location distant from its actual source — is explained by the convergence-projection theory, first proposed by Ruch in 1961: visceral (internal organ) nociceptive afferents and somatic (skin/muscle) afferents from an unrelated body region converge onto the same second-order neurons in the dorsal horn. Because that shared neuron’s axon has, throughout a person’s life, almost always carried signals originating from skin and muscle rather than viscera — nociceptive visceral afferents are comparatively sparse — the brain’s default interpretation of activity on that pathway is “somatic,” regardless of where the input actually originated. The brain has no independent way to check the source; it reads the pathway, not the organ.

Visceral source	Common referred location	Shared convergence pathway
Heart (myocardial ischemia)	Left arm, shoulder, jaw	Cervical/upper thoracic dorsal horn segments shared with those dermatomes
Gallbladder	Right shoulder, upper back	Phrenic nerve segments converging with shoulder somatic afferents
Diaphragm irritation	Shoulder tip	Shared C3-C5 spinal segments (phrenic nerve origin)
Appendix (early appendicitis)	Periumbilical region, later migrating to right lower quadrant	Visceral afferents entering at T10 before localized somatic peritoneal irritation develops

This is not a rare curiosity — it’s a routinely dangerous diagnostic trap by design, which is exactly why “left arm pain” is a standard part of heart attack symptom education despite the heart itself being nowhere near the arm.

The Volume Knob: Descending Modulation

The spinal gate is not the only place pain gets adjusted — the brain itself actively modulates incoming nociceptive signals through a well-characterized descending pain modulatory system, anchored by the periaqueductal gray (PAG) in the midbrain and the rostral ventromedial medulla (RVM) in the brainstem. This PAG-RVM-dorsal horn axis is bidirectional: it can either inhibit or facilitate nociceptive transmission at the spinal cord, and it does so partly through endogenous opioid signaling — the body’s own morphine-like peptides, released to inhibit specific RVM neurons and produce measurable analgesia without any external drug involved.

This descending system is the physiological basis for phenomena that otherwise sound implausible: soldiers and athletes sustaining injury without noticing pain until well after the acute event, placebo analgesia measurably reducing both pain reports and objective neural activity, and stress-induced analgesia in general. It’s also the target, alongside peripheral opioid receptors, of exogenous opioid medications — which is precisely why they’re such effective analgesics and precisely why they carry a genuine dependency risk: the same descending circuitry that dampens pain sits adjacent to, and interacts with, the brain’s broader reward and reinforcement machinery.

When the System Breaks: Central Sensitization

Every mechanism described so far assumes the nervous system is faithfully relaying and modulating a real, ongoing peripheral signal. Chronic pain frequently breaks that assumption. Repeated or intense C-fiber input can trigger wind-up — a well-documented phenomenon where dorsal horn neurons respond to a constant-intensity repeated stimulus with a progressively amplified output, driven substantially by NMDA receptor upregulation and calcium-mediated intracellular signaling cascades. Sustained wind-up can produce lasting central sensitization: NMDA receptor upregulation, expansion of neurons’ receptive fields, reduced GABA/glycine inhibitory tone, and altered descending modulation, collectively lowering the threshold at which pain gets triggered and broadening the area over which it’s felt.

The clinically important consequence is that this state can persist as a stable, self-sustaining “pain memory trace” in spinal and cortical circuits well after the original tissue injury has fully healed — the nervous system’s own wiring, not ongoing tissue damage, becomes the thing generating the pain signal. This is significant enough that in 2017 the International Association for the Study of Pain formally added a third mechanistic category to its classification system, alongside the two long-established categories:

IASP pain category	Definition	Example
Nociceptive	Pain from activation of nociceptors by actual/threatened tissue damage, normal-functioning nervous system	A burn, a fracture, acute inflammation
Neuropathic	Pain caused by a lesion or disease of the somatosensory nervous system itself	Diabetic neuropathy, post-herpetic neuralgia
Nociplastic	Pain from altered nociceptive processing, with no clear evidence of tissue damage or nerve lesion causing it	Fibromyalgia, many cases of chronic low back pain

Nociplastic pain is not a diagnosis of exclusion in the dismissive sense — it describes a real, measurable neurophysiological state (allodynia, where normally non-painful stimuli become painful, and hyperalgesia, an amplified response to painful stimuli, are its clinical signatures), distinct from either straightforward tissue damage or a diagnosable nerve lesion. It is the formal, technical answer to why “the scan looks fine but the pain is real” is not a contradiction.

Honest Trade-offs

Chronic pain is not a niche problem: CDC survey data from 2023 puts the prevalence of chronic pain lasting three months or longer at 24.3% of U.S. adults, with 8.5% experiencing high-impact chronic pain severe enough to restrict daily activities — both figures that have risen from 20.4% and a smaller high-impact share measured in 2016, though how much of that rise reflects better recognition versus a genuine increase is an open question the underlying surveys can’t fully resolve on their own. The gate-control mechanism, while real and mechanistically well-supported, has produced therapies — TENS units chief among them — with genuinely mixed clinical trial evidence for chronic pain specifically, even though the underlying physiology explaining why rubbing an acute injury helps is solid; a real mechanism does not automatically guarantee a durable clinical treatment built on it. And the descending opioid modulation system is a real double bind, not a marketing talking point: the same neural machinery that makes opioids powerful analgesics is intertwined with reward circuitry closely enough that dependency risk is a structural feature of the mechanism, not a dosing mistake to be engineered away. None of this makes chronic pain, or nociplastic pain specifically, any less real or “psychological” in the dismissive sense — it means the nervous system generating it is doing exactly what a system with these known failure modes (wind-up, reduced inhibitory tone, receptive field expansion) would be expected to do once pushed into that state.

Verdict

Pain is a multi-stage signal-processing pipeline, not a single sensor reading, and every stage in this post — peripheral fiber type, the spinal gate, convergence with unrelated somatic pathways, descending brainstem modulation, and the plasticity of the dorsal horn itself — is an independent point where the relationship between tissue damage and the conscious experience of pain can bend or break. That architecture explains real, useful phenomena (rubbing an injury, TENS, referred cardiac pain as a genuine diagnostic signal) and it also explains, with the same mechanisms, why chronic pain can become a self-sustaining property of the nervous system rather than a symptom pointing back to ongoing damage. The IASP’s 2017 addition of nociplastic pain as a formal third category is the clearest signal that this isn’t fringe science — it’s the field’s own acknowledgment that the old two-category model (something’s damaged, or a nerve is diseased) left out a large, real, and now separately named class of pain generated by the processing system itself.